Navigation Links
CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
Date:9/17/2007

VIENNA, Va., Sept. 17 /PRNewswire-FirstCall/ -- CEL-SCI Corporation (AMEX: CVM) announces that its Chief Executive Officer, Geert Kersten, is a featured presenter at the Biotech/Pharma/Healthcare On-line Forum. The webcast presentation is scheduled for Tuesday, September 18, 2007 at 9:30 a.m. (Eastern Daylight Time) and can be accessed via the Internet at CEL-SCI's website http://www.cel-sci.com or http://www.investorcalendar.com/ClientPage.asp?ID=119627. If you are unable to participate during the live webcast, the call will be available for replay.

CEL-SCI Corporation is developing products that empower immune defenses. Its lead product is Multikine(R). In Phase II clinical trials Multikine was shown to be safe and well-tolerated, and to improve the patients' overall survival by 33% at a median of three and a half years following surgery. The U.S. Food and Drug Administration (FDA) gave the go-ahead for a Phase III clinical trial with Multikine in January 2007 and granted orphan drug status to Multikine in the neoadjuvant therapy of squamous cell carcinoma (cancer) of the head and neck in May 2007.

Multikine, a patented defined mixture of naturally derived cytokines, is the first immunotherapeutic agent in a new class of drugs called "Immune SIMULATORS". Immune SIMULATORS simulate the way our natural immune system acts in defending us against cancer. As opposed to other immunotherapies which are designed to target a single or limited number of specific antigens or molecules, Immune SIMULATORS are multi-targeted; they simultaneously cause a direct and targeted killing of t
'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. CEL-SCIS CEL-1000 Shown to Significantly Enhance Immune Response Against Avian Flu Antigen in Animals
2. CEL-SCI Presents Long-Term Cancer Survival Data With Multikine
3. CEL-SCIs Cel-1000 Shown to Significantly Enhance Immune Response Against Hepatitis B Antigen in Animals
4. The Past, Present and Future of HLA Typing
5. Sygnis Pharma AG announces date for presentation of clinical results
6. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
7. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
9. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
10. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
11. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... , March 31, 2015  The efficacy of continuous ... in a recently published study 1 of ultraviolet ... research team, including Curtis Donskey , M.D.  The ... for the same length of time from the same ... unit.  The results showed surprisingly low pathogen kill rates ...
(Date:3/31/2015)... According to a new ... Market (Chromatography, Electrophoresis, DNA Sequencer, PCR, Microplate Reader, Robotics, ... Centrifuge) - Global Forecast to 2019", published by ... Market is expected to reach $48.84 Billion by ... 2019. Browse   9 ...
(Date:3/31/2015)... Calif. , March 31, 2015  Frequentz Inc., ... has released a white paper to help the pharmaceutical ... 2013 Drug Supply Chain Security Act (DSCSA). The white ... stages of the GS1 EPCIS Standard(s) and ... outlook on the product tracing requirements that need to ...
Breaking Medicine Technology:VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 2VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 3VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 4Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 2Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 3Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 4Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 5Frequentz Releases White Paper Addressing DSCSA's Current & Future Impact 2Frequentz Releases White Paper Addressing DSCSA's Current & Future Impact 3
... Causing Mitochondrial Disease More Common Than Previously,Believed, ... (UMDF) today announced landmark research finding that,one in ... could potentially cause a,mitochondrial disease in them or ... fatal disease, and mitochondrial disorders are at,the core ...
... Sanofi-aventis,(EURONEXT: SAN and NYSE: SNY) announced today ... priority review status for its New Drug,Application (NDA) ... July 31, 2008., The priority review is ... new drug product, if approved, has the potential ...
Cached Medicine Technology:New Research Shows One in 200 People Born with DNA Mutation That Can Lead to Devastating, Often Fatal Disease 2New Research Shows One in 200 People Born with DNA Mutation That Can Lead to Devastating, Often Fatal Disease 3Multaq(R) (dronedarone) Granted FDA Priority Review for Patients with Atrial Fibrillation 2Multaq(R) (dronedarone) Granted FDA Priority Review for Patients with Atrial Fibrillation 3
(Date:3/31/2015)... Plains, NJ (PRWEB) March 31, 2015 Dr. ... On March 19th, Dr. Parvez conducted Grand Grounds Presentations ... on “Prescribing Opioids and Managing Side Effects”. The event ... attending physicians. She received very positive feedback from the ... of the best that they’ve had in a while. ...
(Date:3/31/2015)... of the most beautiful and awe-inspiring aspects of a Hawaiian dream ... island. The big island of Hawaii, after all, is one ... oozing at your feet in one of the most sought after ... never expect to see a live volcano spewing ash and lava ... now. , Members of a local and independently owned Gold’s Gym ...
(Date:3/31/2015)... BESLER Consulting today announced the publication ... an Independent Cost Report Review.” , The Medicare ... in the determination of Medicare reimbursement to hospitals ... review, this report can assist management in future ... white paper discusses:,     The anatomy ...
(Date:3/31/2015)... Array Health , a leading provider of ... Hood, Senior Director of Marketing, will present at The ... 1, 2015. The session, co-presented with Brian Ridder, Vice ... can streamline and simplify the private exchange shopping, enrollment ... and Employer Needs in a Private Exchange – From ...
(Date:3/31/2015)... 31, 2015 More than 120 of ... to express their shared support for the same basic ... a 'True Health Coalition' and a lifestyle medicine initiative ... help demonstrate that, despite appearances to the contrary, there ... about the theme of healthful eating and living. ...
Breaking Medicine News(10 mins):Health News:NJ Top Docs Presents, Dr. Uzma Parvez of Total Pain Care 2Health News:Rare Volcano Constructed inside Gold’s Gym in Mission, Texas 2Health News:Rare Volcano Constructed inside Gold’s Gym in Mission, Texas 3Health News:Array Health’s Senior Director of Marketing to Co-Present with Benaissance at The Institute for HealthCare Consumerism Private Exchange Forum 2Health News:GLiMMER Initiative Founder David Katz, MD Announces the Launch of the True Health Coalition: Worldwide Experts Convened to Defend Fundamentals of Healthy Eating/Living 2Health News:GLiMMER Initiative Founder David Katz, MD Announces the Launch of the True Health Coalition: Worldwide Experts Convened to Defend Fundamentals of Healthy Eating/Living 3Health News:GLiMMER Initiative Founder David Katz, MD Announces the Launch of the True Health Coalition: Worldwide Experts Convened to Defend Fundamentals of Healthy Eating/Living 4
... TUESDAY, Jan. 25 (HealthDay News) -- Epilepsy was the likely ... Chopin, according to a new study. Researchers reached the ... musician,s own descriptions of his hallucinations -- including his description ... of his life written by pupils and friends such as ...
... Reinberg HealthDay Reporter , TUESDAY, Jan. 25 (HealthDay ... the U.S. Food and Drug Administration is asking an expert ... held to stricter standards. Over the past five years, ... used to shock a patient in cardiac arrest in hopes ...
... investigation and a blood test to measure the level of ... heart failure following acute coronary syndromes. This is the conclusion ... Acute coronary syndromes, such as myocardial infarction and unstable ... care and death in Sweden for both women and men. ...
... the AACR 102nd Annual Meeting 2011 is Friday, Feb. 25. ... editors and reporters, and we cannot guarantee that housing will ... will feature the latest findings in laboratory, translation and clinical ... meeting, including: nicotine supplements and tumor growth ...
... human immunodeficiency virus (HIV) impaired results of transplant ... patients dropping off the transplantation wait list. The ... was not impacted following liver transplantation in patients ... center studythe largest to dateare published in the ...
... studied the defences used by caterpillars that transform into ... regurgitate semi-digested cabbage leaves to make them smell and ... that frequent use of this defence reduces the caterpillars, ... It remains unclear why their defences affect them ...
Cached Medicine News:Health News:FDA Looking for Tougher Standards for External Defibrillators 2Health News:Ultrasound and a blood test can increase survival after myocardial infarction 2Health News:The American Association for Cancer Research hosts its 102nd Annual Meeting 2Health News:Patients infected with HIV have higher drop-out rate for liver transplantation 2Health News:Insects that deter predators produce fewer offspring 2
... designed to optimize the accuracy and precision ... products is widely recognized by customers throughout ... extended over the years and now covers ... tips including filter tips, certified pure tips, ...
... Processor is a primary component of an ... processing, sampling, and slide preparation all ... MonoPrep LBP Processor produces high-quality sample slides ... range of cytology specimen types. It processes ...
... innovative, quick and easy automated refill ... less space on your laboratory bench ... amazingly easy-to-use, one-hand system, you only ... range of Diamond Tips. All sizes ...
200 L, Racked, Pre-sterilized, 96 tips/rack, clear Recommended for 20, 25, 50, 100 and 200 L pipettes. Can also be used with 300 L pipettes when pipetting 200 L or less....
Medicine Products: